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Protein nanocrystallography, a new technology for crystal growth based on
protein nanotemplates, has recently been shown to produce diffracting, stable
and radiation-resistant lysozyme crystals. This article, by computing these
lysozyme crystals’ atomic structures, obtained by the diffraction patterns of
microfocused synchrotron radiation, provides a possible mechanism for this
increased stability, namely a significant decrease in water content accompanied
by a minor but significant -helix increase. These data are shown to be
compatible with the circular dichroism and two-dimensional Fourier transform
spectra of high-resolution H NMR of proteins dissolved from the same
nanotemplate-based crystal versus those from a classical crystal. Finally,
evidence for protein direct transfer from the nanotemplate to the drop and
the participation of the template proteins in crystal nucleation and growth is
provided by high-resolution NMR spectrometry and mass spectrometry.
Furthermore, the lysozyme nanotemplate appears stable up to 523 K, as
confirmed by a thermal denaturation study using spectropolarimetry. The
overall data suggest that heat-proof lysozyme presence in the crystal provides a
possible explanation of the crystal’s resistance to synchrotron radiation.
Keywords: protein crystals; mass spectroscopy; NMR; CD.
1. Introduction
The term ‘protein nanocrystallography’ (Pechkova & Nicolini,
2003, 2004a; Nicolini & Pechkova, 2004) has been accepted by
both crystallographic (e.g. Pechkova et al., 2003) and nano-
technological (e.g. Pechkova & Nicolini, 2002b) communities.
Protein nanocrystallography has been defined as being at
the intersection between nanotechnology and proteomics.
This emerging field results from the combination of advanced
nanotechnologies, particularly atomic force microscopy , thin-
film nanotemplate technology, nanogravimetry and micro-
focused synchrotron radiation. It should be noted that nano-
crystallography does not refer to the study of self-assembled
organic and inorganic crystals of nanometer size or nano-
particles. In addition, it does not refer to the nanodrop or
microdrop crystallization technology resulting from the
exciting advances made in microfluid chips (Thorsen et al.,
2002).
Furthermore, the term does not refer to so-called protein
nanocrystals; the protein nanocrystalline state or powder
consists of aggregates smaller than 1 mm in size, usually
occurring in the amorphous precipitate, the method of
preparation and characterization of this nanocrystalline
matter being the same as that of the large crystals obtained
with increased concentration of the protein and/or the preci-
pitant (Martin & Zilm, 2003). A more appropriate termi-
nology would be ‘protein nanoaggregates’, even if in some
cases these substances have been proved to be ordered. In
order to see real crystal order, one needs to consider the
micrometre size.
In summary, we can properly refer to nanocrystallography
only when the method of crystallization and characterization
is based on nanotechnology. Protein nanocrystallography has
indeed been successful in crystallization of proteins that had
not previously been crystallized, such as membrane protein
cytochrome P450scc (Pechkova & Nicolini, 2002a,b; Nicolini
& Pechkova, 2004), and in solving the structures of proteins
that were previously unknown, for example CK2 human
kinase (Pechkova & Nicolini, 2004b), pointing to a very
promising nanotechnology-based approach in structural
proteomics.
Lysozyme is a hydrolase enzyme (EC 3.2.1.17) which,
thanks to exceptional ease of crystallization, is frequently used
as an example in protein crystallization studies, such as
investigations into the effects of impurities, pH and tempera-
ture on crystallization mechanisms (Yoshizaki et al., 2004);
studies of nucleation rates (Forsythe et al., 2002; see Garcia-
Ruiz, 2003 for review); microscopic (atomic level) mathema-
tical modelling including statistical mechanics and lattice
simulations of nucleation (see Kierzek & Zielenkiewicz, 2001
for review); macroscopic mathematical modelling of crystal-
lization kinetics (Manno et al., 2003; Agena et al., 1999; Bessho
et al., 1994); and X-ray topography and diffraction analysis of
crystal perfection, growth, quality, response to humidity and
dislocations (Tachibana et al., 2003; Hu et al., 2001; Dobrianov
et al., 2001, 1998; Boggon et al., 2000).
Lysozyme is also routinely used as a test object when a new
technique needs to be verified (Adachi et al., 2004; Kadowaki
et al., 2004; van der Woerd et al., 2003; Sanjoh et al., 2001;
Penkova et al., 2002; Tsekova et al., 1999; Chayen et al., 2001).
In our work, lysozyme was initially used as a model protein in
the investigation of the influence of Langmuir–Blodgett (LB)
nanofilms on crystallization, crystal quality, and eventual
structure of the protein and its aqueous environment in the
crystal. We initially found that LB coating on the cover slide of
common crystallization plates leads to stimulation of protein
crystal growth, allowing the acceleration of the lysozyme
crystal growth rate compared with the classical vapour diffu-
sion method (Pechkova & Nicolini, 2001). Radiation-stable
microcrystals with pronounced diffraction patterns were then
reproducibly obtained by the nanotechnology-based method
(Pechkova & Nicolini, 2003, and references therein) for
proteins cytochrome P450scc and human kinase CK2, for
which attempts at crystallization using conventional methods
were unsuccessful. It is important to note that the use of
microcrystals for X-ray diffraction studies requires micro-
focused synchrotron radiation, and therefore a higher flux
density than that used for routine protein crystallography with
synchrotron radiation was applied to the crystals.
However, atomic resolution structure has been derived at
the ESRF microfocus beamline from minuscule protein
microcrystals with diameters of 20 mm, for which attempts at
crystallization using conventional methods were unsuccessful
(Pechkova & Nicolini, 2004b; Pechkova et al., 2003). The
solution of the crystal structure required a high flux density of
microfocused synchrotron radiation. In the course of data
collection on these proteins and on lysozyme crystals obtained
by the nanotemplate method, it appeared that the crystals
showed a particularly long lifetime in the beam, which
suggested less sensitivity to radiation damage (Pechkova et al.,
2004). The aim of the present report is to obtain data of a more
quantitative nature on this phenomenon and to propose a
model.
The exact mechanism by which the presence of LB nano-
films accelerates and guides crystallization is not clear, even
though it is quite evident that the primary physical factor is the
anisotropy rendered by the film to the growing crystal. This
anisotropy possibly has an electrostatic nature, since dipole
moments of protein monomers are oriented identically in the
film, as confirmed by surface potential measurements (Pech-
kova & Nicolini, 2003, and references therein).
The present study attempts to determine whether intro-
duction of an LB nanofilm modifies the three-dimensional
structure of the protein and/or the configuration of water
molecules surrounding the protein. We determined the three-
dimensional atomic structure of lysozyme in the nanofilm-
based and the classical crystals with synchrotron radiation
using the molecular replacement method and by 1H NMR
spectrometry. Apart from the above considerations, we chose
lysozyme because any improvement of the crystal quality
upon LB film introduction, considering that the quality of the
classical lysozyme crystals is already high, could imply that the
method has enormous potential for proteins that are not so
readily crystallizable.
Furthermore, in order to understand the role of the nano-
template in lysozyme crystallization, we used flourescein
labelling of the proteins forming the LB film used as the
nanotemplate. Fluorescein labelling of proteins is usually
performed through either the side-chain amino group of a
lysine residue or the side-chain sulfhydryl group of a cysteine
residue, using commercially available linkers. The side-chain
amino group labels include fluorescein–succinimidyl deriva-
tives for specific labelling of NH2 sites (Vives & Bernard,
2003). We used carboxyfluorescein succinimidyl ester (CFSE)
rather than fluorescein isothiocyanate, resulting in more reli-
able labelling. The crystals obtained in the presence of CFSE-
labelled templates were analysed by 1H NMR spectrometry
and mass spectrometry in order to establish if template
proteins directly transfer from the nanofilm to the drop
solution and participate in crystal formation.
2. Methods
Chicken egg-white lysozyme was purchased from Sigma.
2.1. Fluorescein labelling of lysozyme
A solution of CFSE with a concentration of 1.5 mg mlÿ1 was
prepared in anhydrous dimethylsulfoxide. A CFSE solution
(100 ml) was added to a protein lysozyme solution (1 ml) with
a concentration of 1 mg mlÿ1. The mixture was incubated for
90 min in the dark at room temperature with continuous
gentle agitation. Labelled protein was separated from free
fluorescein compounds by extensive dialysis versus phosphate-
buffered saline (overnight). The protein was concentrated
with Centricon concentrators up to 40 mg mlÿ1, centrifuged
for 10 min at high speed and filtered through a 0.22 mm filter.
2.2. Lysozyme nanotemplate formation and crystallization
Lysozyme or CFSE-labelled lysozyme (about 600 ml with
concentration 40 mg mlÿ1) was spread on the air–water
interface of an LB trough and compressed by surface pressure
(20 mN mÿ1). The protein monolayer was transferred by the
Langmuir–Schaeffer method onto the siliconized glass cover
slide used for crystallization. Lysozyme crystallization by the
classical method and by nanotemplating are described in
detail by Pechkova & Nicolini (2001).
nanobioscience
J. Synchrotron Rad. (2005). 12, 772–778 E. Pechkova et al.  Protein nanocrystallography 773
2.3. Synchrotron radiation
Diffraction data were collected at a temperature of 100 K.
Crystals were removed from the mother liquor and frozen in a
nitrogen stream using cryoprotectant from Hampton
Research. One nanotemplate and one classical crystal of the
same dimensions (see Fig. 1) were used to collect the complete
data sets at the microfocus beamline ID-13 at the ESRF
(Riekel, 2004). The beam size was 5 mm  5 mm; the wave-
length used was 0.9755 A˚ and the crystal-to-detector distance
was 100 mm. Crystals diffracted to a maximum resolution
of 1.7 A˚.
The lysozyme crystals belong to space group P43212, with
unit-cell parameters (classical/LB-based) a = b = 78.89/79.21 A˚
and c = 37.16/37.42 A˚. One molecule is present in the asym-
metric unit. Assuming a molecular mass of approximately
14000 Da, the VM coefficient is about 2.09 A˚. Standard
procedures of data reduction were followed using the
MOSFLM and SCALA programs from the CCP4 suite (Wild
et al., 1995). The phase problem was solved using the mol-
ecular replacement method using the software package CNS
(Bru¨nger et al., 1998), and the three-dimensional structure was
determined from a map using the software packageQUANTA
(http://www.accelrys.com/quanta/quanta.html), via map skele-
tonization and secondary-structure determination, and the
package XtalView (McRee, 1992), via direct fitting of C
atoms. Refinement was performed manually using both
packages, and finally by the CCP4 program REFMAC5.
2.4. Nuclear magnetic resonance spectroscopy
1H NMR experiments were recorded on a Bruker AMX
500 MHz device on a Silicon Graphics SGI O2 (OS IRIX 6.3).
The probe temperature was maintained at 300 K, and water
suppression was carried out using a watergate and the
DPFGSE scheme. The spectral width was about 16 p.p.m.
(Pulsinelli et al., 2003).
The sample for NMR measurements was obtained by
dissolving a sufficient number of crystals in water (0.5 ml, with
10% D2O) to obtain a 0.6–0.8 mM concentration. The NMR
spectra were analysed using the XEASY program (Bartels et
al., 1995). As reference for protein assignment we take into
account the work of Redfield and co-workers (Redfield et al.,
1998).
2.5. Mass spectrometry methods
The mass spectrometry measurements were performed on a
Bruker Autoflex matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometer (Bruker
Daltonics, Leipzig, Germany) to monitor the purity of the
protein solutions before and after being crystallized and to
verify the presence of CFSE-labelled molecules in the crystal.
The control sample of a 2 nM solution of lysozyme was
prepared by dissolving protein lyophilized powder (Sigma–
Aldrich) in 0.1% trifluoroacetic acid (TFA). Lysozyme crystals
obtained by nanotemplate and CFSE-labelled nanotemplate
methods were dissolved in 0.1% TFA for analysis.
For protein fingerprinting, the lysozyme samples were
digested with trypsin; the sample was dissolved/diluted in
100 mM ammonium bicarbonate (Sigma–Aldrich) pH 8.5,
and trypsin dissolved in 1 mM HCl to a concentration of
1 mg mlÿ1 was added. The solutions were incubated for 3 h
at 310 K.
The matrix used for the mass spectrometry analysis was a
saturated solution of -cyano-4-hydroxycinnamic acid
(Bruker Daltonics) dissolved in a mixture of two-thirds 0.1%
TFA and one-third acetonitrile. Analytes were spotted onto an
aluminium plate. We used the ‘dried droplet method’ for the
sample deposition; before deposition, the matrix was mixed in
with the sample, and then 1 ml of this mixture was deposited on
the plate. The final concentration utilized for each sample
was 1 nM.
The obtained mass lists were compared with database lists
for the protein identification (Bonk & Humeny, 2001). For
protein data interpretation we used the Biotools software
(Bruker Daltonics), which allows automated protein identifi-
cation via a library search and has MASCOT intranet search
software (Matrix Sciences) fully integrated. We analysed three
lysozyme samples (lyophilized powder dissolved in 0.1% TFA,
marked lysozyme and pure lysozyme crystals dissolved in
0.1% TFA). For the intact protein analysis we used a MALDI
mass spectrometer in linear mode, with a scanning range from
4 to 20 kDa, obtaining a resolution of about 500; for the
analysis of the peptides obtained from the tryptic digestion of
the samples, we used the mass spectrometer in reflectron
nanobioscience
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Figure 1
Lysozyme crystal prepared (a) by the classical hanging-drop method and
(b) by the nanobiofilm template method after 500 s of intense focused
radiation exposure. (c) Number of reflections versus time of radiation
exposure for lysozyme crystals grown with (black line) and without (grey
line) a nanobiofilm template.
mode, with a scanning range between 500 and 2000 Da,
obtaining a resolution between 2000 and 6000. To calibrate the
mass spectrometer we used protein and peptide calibration
standard solutions (Bruker Daltonics).
2.6. Circular dichroism (CD)
CD spectra were recorded on a Jasco J-700 spectro-
polarimeter at physiological ionic strength. All spectra were
recorded in a nitrogen atmosphere at room temperature using
a 0.05 cm path-length quartz cell. Each spectrum is an average
of ten scans over 300–190 nm.
3. Results
The crystals formed by nanotemplating are dramatically
different from classical crystals in terms of stability to
synchrotron radiation, as proven in Fig. 1. In the classical
crystal, the number of reflections in the diffraction pattern
decay quite fast and damage appears only 500 s after exposure
(for details see Pechkova et al., 2004).
To facilitate comparison of the differences in the structures
derived from classical and LB-based crystals, we assessed the
overall characteristics of the crystals by comparing the initial
reflection data, the maps derived from them and the three-
dimensional structures obtained. These results are summar-
ized in Table 1.
Generally, the differences between the structures of the
lysozyme molecules themselves are very small: only about
0.28 A˚ r.m.s. difference between the LB-based and the clas-
sical structures when they are superimposed. After refine-
ment, this difference reduces to 0.17 A˚. However, the
lysozyme molecules appear oriented differently with respect
to the crystal axes; this difference might be related to differ-
ences in hydrogen bonding with water molecules.
This supposition prompted us to analyse the arrangement
of water molecules around the lysozyme molecule; this
arrangement indeed exhibits a much larger difference. A
smaller number of water molecules were resolved for the LB
crystal at high threshold than for the classical crystal. We have
chosen such a high threshold to be certain that all of the
resolved water molecules immediately adhere to the protein
surface. To estimate how water will surround the lysozyme
molecule in a crystal, water molecules were modelled by
expanding the already resolved water layer, to fill a 60 A˚-
diameter sphere, for both the classical and the LB crystals.
Such a modelling technique repeats the surface topology of
the protein and the adherent water layer, and is therefore
suitable for modelling water in a crystal. At this point, the
difference in water content is estimated to be about 6%
smaller for LB crystals (4669 versus 4933 molecules), which is
augmented by the fact that the unit-cell volume is somewhat
larger (235 versus 231 nm3) for the LB crystals. For proteins, a
higher level of hydrogen bonding invariably leads to increased
secondary-structure content, particularly with respect to
-helices that are largely held together by hydrogen bonds.
Indeed, slightly increased -helicity is observed for the LB
crystal (Table 1).
CD spectra taken between 180 and 250 nm confirm the
minor increase of -helix in a crystal grown by nanotemplate
with respect to the classical crystal (Table 2).
In order to have an additional independent confirmation of
this very critical structural difference we have also analysed,
by 500 MHz H NMR, the conformation of lysozyme crystals
obtained from LB film (Fig. 2). Our goal is to verify if there are
some conformational differences between our crystals and the
lysozyme protein that has not experienced LB packing. The
monodimensional NMR spectra of a protein crystal grown on
LB film and of a lysozyme sample from a classical crystal (not
shown) suggest that the general folds of the molecules are
maintained and only minor differences are evidenced. To
characterize the structure obtained by LB crystals, and to
investigate the difference in helical content as evidenced by
CD spectra (Table 2), we performed (Fig. 2) TOCSY and
NOESY (total correlation and nuclear Overhauser effect
spectroscopy). If we compare our TOCSY spectrum with the
data published by Poznanski et al. (2003), we can observe the
nanobioscience
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Table 2
Secondary structure of water-dissolved lysozyme crystals derived from
the modified vapour diffusion method with (nanotemplate crystal) and
without (classical crystals) lysozyme thin film used as the nanotemplate.
The percentages of the various types of secondary structure are indicated. For
reference, the percentage of -helix in lysozyme thin film is 40%.
-Helix -Sheet -Turn Random coil
Nanotemplate crystals 36.6 25.2 7.4 30.8
Classical crystals 28.4 28.6 10.5 32.5
Table 1
Parameter comparison of reflection data, electron density maps and
three-dimensional structures between the classical and the LB crystals of
lysozyme.
Classical LB-based
Beamline Microfocus ID13,
ESRF
Microfocus ID13,
ESRF
Temperature (K) 100 100
Detector MAR CCD MAR CCD
Wavelength (A˚) 0.9755 0.9755
Space group P43212 P43212
Unit-cell parameters (A˚, ) a = 78.89 a = 79.21
b = 78.89 b = 79.21
c = 37.16, c = 37.42
 =  =  = 90  =  =  = 90
Resolution range 27–1.7 27–1.7
Independent reflections 13046 13598
Map fragmentation (%) 12 5
Total correlation coefficient
between map and three-
dimensional structure†
0.758 0.726
-Helix content, residues 42 45
Quantity of water molecules
resolved per lysozyme molecule
at 100 threshold
63 53
Quantity of water molecules
modelled in a 60 A˚-diameter
sphere (including those
resolved)
4933 4669
† Water is not included because of different quantities of water molecules resolved.
presence of significant differences in the fingerprint regions of
the two spectra.
By comparison with the above fingerprint of a standard
NMR spectrum of lysozyme, the differences in the resonances
of NH/HA suggest a different lysozyme conformation.
In order to discover if our protein from LB crystals differs
from lysozyme from classical crystals, we analysed the region
of the tryptophan side chains in the NOESY spectrum (Fig. 3),
and we observed some difference in the resonance position of
tryptophan aromatic H atoms, indicating that significant small
conformational differences exist between the two analysed
proteins.
From the MALDI mass spectrometer analysis of the intact
protein spectra, we also verified that after crystallization and
the successive dissolution the protein was still pure (Fig. 4a),
corroborating all of the above NMR studies.
Subsequently, we explored the mechanism of crystal
nucleation and growth in the presence of nanotemplates, by
selectively labelling the LB protein film serving as template in
the vapour diffusion and by monitoring its eventual presence
in the crystal being formed. Evidence for protein direct
transfer from the nanotemplate to the drop and the partici-
pation of template protein in crystal nucleation and growth is
indeed provided by high-resolution NMR spectrometry
(Fig. 5) and mass spectrometry (Fig. 4b).
It is possible to note that the CFSE molecule appears bound
to the lysozyme crystal being formed by nanotemplate-based
vapour diffusion, where the CFSE molecule has, in fact, the
expected mass of 473 Da.
Similarly, if we analyse by 1H NMR the complex obtained
between lysozyme and (6)-carboxyfluorescein-N-hydroxy-
succinimide ester (Fig. 5) we observe that the general fold of
nanobioscience
776 E. Pechkova et al.  Protein nanocrystallography J. Synchrotron Rad. (2005). 12, 772–778
Figure 2
500 MHz TOCSY and NOESY (mixing time = 300 ms) spectra of a
lysozyme crystal grown on LB film.
Figure 3
500 MHz NOESY spectrum (mixing time = 300 ms) of a lysozyme crystal
grown on film: He1/Hd1 and He1/Hz2 correlation of tryptophans
(above). If we compare this region with the same range observed by
Kristiansen et al. (1998) (below), we can observe some differences in the
resonance positions of tryptophans aromatic H atoms, indicating small
conformational differences between the two analysed proteins.
the lysozyme is conserved. In fact, the NH regions of the one-
dimensional NMR spectra (even if the spectrum obtained for
the complex, particularly in this region, shows a poor signal-to-
noise ratio as a result of the low concentration of the sample)
show a similar spread of peaks and no significant change in
proton chemical shifts can be observed. On the other hand, in
this region new peaks appear as a result of the fluorescent
ligand and some peaks of the protein are less sharp (compared
with the spectrum of the protein alone) probably due to the
interaction with CFSE.
In the aliphatic region of the spectra, between ÿ2.0 and
4.5 p.p.m., significant differences occur at the level of the peak
at 1.3 p.p.m. and in the multiplicity of the signal at 0.7 p.p.m.,
indicating that the protein experiences some conformational
changes, as a result of binding with fluorescein. Interestingly,
the thermal stability of lysozyme in the nanotemplate appears
higher (up to 523 K) than that for the same protein in solution
(about 348 K), as shown by the dependence of molar ellipticity
at 195 nm on temperature in the range 298–523 K (Fig. 6).
4. Discussion
All of the above data obtained by X-ray synchrotron diffrac-
tion, NMR, circular dichroism and thermal denaturation
point, for the nanotemplate-produced lysozyme crystal, to a
minor but consistent increase in the fraction of -helix, which
appears compatible with the observed decrease in water
content, the increased thermal stability and the increased
resistance to synchrotron radiation.
The LB crystal appears to be superior to the classical crystal
with respect to map fragmentation and map correlation to the
resulting models. The higher quality of the LB crystal with
respect to the classical crystal can again be ascribed to higher
water ordering brought about by the presence of the film. It
nanobioscience
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Figure 6
Molar ellipticity at 196 nm versus temperature for lysozyme LB film
(upper grey line) as compared with lysozyme solution (lower black line).
Figure 5
NMR spectra of a lysozyme crystal (a) and of a lysozyme/fluorescein
complex (b). The region between ÿ2.0 and 4.5 p.p.m. is shown.
Figure 4
(Top) In black, the spectrum of pure lysozyme from lyophilized powder
dissolved in 0.1% TFA, and in red, the spectrum of a marked lysozyme
crystal. The three peaks were assigned as [m]+ for m/z = 14307.785, [m]2+
(double charge) for m/z = 7149.769 and [m]3+ (triple charge) for m/z =
4763.4763. There is no evidence of peak shifts. (Bottom) Low weights
detail: in black, the spectrum of pure lysozyme, and in red, the spectrum
of a marked lysozyme crystal. The peak at 474 Da (CFSE) is evidently
present only in the red spectrum.
should be noted that the estimated protein dehydration in the
crystal parallels that reported for protein in an LB film
(Nicolini, 1997).
Comfortingly, in the present communication, which aimed
also to investigate the lysozyme crystal growth mechanisms
with and without nanotemplating, lysozyme appears to
transfer directly from the nanostructured film to the drop to
trigger the formation of the crystal, therefore highlighting the
physical interpretation of the mechanism for nanotemplate-
induced protein crystallization.
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